MATTHEW WILLIAMS: Open Payments
NPI 1144749359 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 25 payments from 16 companies in 2025. Trend: 2023 $450 · 2024 $682 · 2025 $539
Food & beverage: $470Education: $68
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Janssen Biotech, Inc. | 3 | $61 |
| BeOne Medicines USA, Inc. | 3 | $57 |
| MENARINI SILICON BIOSYSTEMS, INC. | 2 | $53 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Genentech USA, Inc. | 2 | $33 |
| Caris MPI, Inc. | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
Products named: IMFINZI, Cellsearch, BRUKINSA, MI CANCER SEEK, CARVYKTI, DARZALEX, TEVIMBRA, clonoSEQ.
Industry payments across NJ — which companies pay providers there.
